The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX. (Q46533539)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 June 2008

Language	Label	Description	Also known as
English	The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX.	scientific article published on 18 June 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Richard Bruggeman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

B Wilffert

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A F Y Al Hadithy

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

V J Sing

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

G Matroos

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J R B J Brouwers

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

P N van Harten

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

0 references

publication date

18 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

652-659

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Pharmacogenomics in schizophrenia: the quest for individualized therapy.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

High vulnerability to acute dystonic reactions: a case of antipsychotic exposure and uncontrolled seizure activity

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Comparative Doses and Costs of Antipsychotic Medication

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Ethnicity and antipsychotic response

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Tardive dyskinesia is not associated with the polymorphisms of 5-HT2A receptor gene, serotonin transporter gene and catechol-o-methyltransferase gene ⋆

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Tardive Dyskinesia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

No correlation between A(-1438)G polymorphism in 5-HT2A receptor gene promoter and the density of frontal cortical 5-HT2A receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Tardive dystonia and genetic polymorphisms of cytochrome P4502D6 and dopamine D2 and D3 receptors: a preliminary finding

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Clinical potential of respirable antisense oligonucleotides (RASONs) in asthma

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Ethnicity and the course of tardive dyskinesia in outpatients presenting to the motor disorders clinic at the Maryland psychiatric research center

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Association of a polymorphism in the promoter region of the serotonin 5-HT2C receptor gene with tardive dyskinesia in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Familial occurrence of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46533539&oldid=1407058569"